Mel Gibson's cancer drug claim on Joe Rogan's podcast has sparked a heated debate and raised concerns among medical professionals. The actor-director's statement, which gained over 60 million views in its first month, has led to a dramatic surge in prescriptions for an unproven cancer treatment. Gibson claimed that three friends with Stage 4 cancer were cured after taking a combination of ivermectin and fenbendazole, an off-label regimen not approved for human use by the FDA. This claim has had a significant impact on prescription trends, particularly among young men, white patients, and those in the South. However, experts caution that there is little clinical evidence to support the use of these drugs for cancer treatment. Laboratory studies have shown some anti-cancer activity, but the doses required for even a modest effect would typically be considered toxic in humans. Dr. Skyler B. Johnson of the University of Utah Huntsman Cancer Institute expressed concerns about the potential interference of ivermectin with cancer treatments and other medications. To date, no human clinical trials have demonstrated the safety or effectiveness of ivermectin and fenbendazole for cancer treatment. The study's authors, Dr. John N. Mafi and Dr. Katherine Kahn, emphasized the risks of following unproven advice, especially when it leads to patients skipping or delaying proven cancer treatments. The UCLA-led study highlights the need for further research to explore the potential harm caused by these unproven treatments and the doctors prescribing them. The National Cancer Institute's ongoing study of ivermectin's anti-cancer properties is still in the preclinical stage, and high-quality evidence in humans is lacking. This incident raises important questions about the influence of celebrity endorsements on health information and the potential for rapid shifts in medical practices. It also underscores the need for timely and trustworthy information to guide patients and healthcare providers in making informed decisions.
